Meso RFA

The Mesothelioma Research Foundation of America

(MRFA) is a not-for-profit organization with a mission:  fund research that will lead to the quickest cure for mesothelioma.  Sadly, mesothelioma, a cancer of the lining of the lungs caused by asbestos exposure, has very few treatment options at this time.  Since the year 2001, the foundation has funded the opening of the Mesothelioma Laboratory under the supervision of Dr. Gill at the University of Southern California's Norris Comprehensive Cancer Center.  Norris is one of the largest of the National Cancer Institute's sponsored and funded cancer research facilities. 

The board members are:  United Association International Representative James W. Kellogg, Board Member; Jerry Neil Paul, Founding Director; Elizabeth Ann Paul, Executive Director; and Dr. Parkash Gill, M.D., Chairman of the Medical Advisory Board, USC/Norris Comprehensive Cancer Center in Los Angeles.  Dr. Gill (a board certified oncologist and hematologist) has received FDA approval to conduct clinical trials on a new mesothelioma treatment drug called Veglin, whose research was 100% funded by the the Mesothelioma Research Foundation of America.  It proved successful in Phase I trials.  Phase II trials for Veglin are ongoing.

If you want to participate in Dr. Gill's clinical trials or just want to ask him a question, see the MRFA website, or call 800 909-MESO (6376).